tuberculosis
The test uses mass spectrometry to measure an M. tuberculosis peptide and could be used for diagnosing the disease and monitoring response to treatment.
The project, being coordinated by UCSF and the University of Heidelberg, has a total budget of $20 million and is expected to run through 2025.
BioMérieux Interferon Gamma Release Assay for Latent TB Gets CE Mark
The test is fully automated from sample to result interpretation and requires one whole-blood sample tube with no manual sample preparation necessary.
WHO Updates Recommendations for Point-of-Care Testing for Children, Monitoring of HIV Treatment
The agency said it strongly recommends the use of POC nucleic-acid testing to diagnose HIV in infants and children younger than 18 months.
Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.
Jan 7, 2021
PerkinElmer to Buy Oxford Immunotec for $591M
Oct 13, 2020
Qiagen Preliminary Q3 Revenues Up 26 Percent
Sep 30, 2020
BARDA Exercises $10.5M Option on T2 Bio Contract
May 5, 2020
Oxford Immunotec Q1 Revenues Fall 6 Percent
Mar 24, 2020